Skip to content
healthcare.dev

Olanzapine

NDC 71209-075, Olanzapine, tablet, from Cadila Pharmaceuticals Limited.

Product NDC
71209-075
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210022
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE7.5 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
71209-075-017120900750130 TABLET in 1 BOTTLE (71209-075-01)
71209-075-0571209007505100 TABLET in 1 BOTTLE (71209-075-05)
71209-075-1071209007510500 TABLET in 1 BOTTLE (71209-075-10)
71209-075-11712090075111000 TABLET in 1 BOTTLE (71209-075-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2ae07ad4-4e58-4740-9f02-035ec061fefc

Use it

Look up 71209-075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.